1318 related articles for article (PubMed ID: 16474146)
1. A single amino acid substitution in the West Nile virus nonstructural protein NS2A disables its ability to inhibit alpha/beta interferon induction and attenuates virus virulence in mice.
Liu WJ; Wang XJ; Clark DC; Lobigs M; Hall RA; Khromykh AA
J Virol; 2006 Mar; 80(5):2396-404. PubMed ID: 16474146
[TBL] [Abstract][Full Text] [Related]
2. Analysis of adaptive mutations in Kunjin virus replicon RNA reveals a novel role for the flavivirus nonstructural protein NS2A in inhibition of beta interferon promoter-driven transcription.
Liu WJ; Chen HB; Wang XJ; Huang H; Khromykh AA
J Virol; 2004 Nov; 78(22):12225-35. PubMed ID: 15507609
[TBL] [Abstract][Full Text] [Related]
3. A single amino acid substitution in the central portion of the West Nile virus NS4B protein confers a highly attenuated phenotype in mice.
Wicker JA; Whiteman MC; Beasley DW; Davis CT; Zhang S; Schneider BS; Higgs S; Kinney RM; Barrett AD
Virology; 2006 Jun; 349(2):245-53. PubMed ID: 16624366
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of interferon signaling by the New York 99 strain and Kunjin subtype of West Nile virus involves blockage of STAT1 and STAT2 activation by nonstructural proteins.
Liu WJ; Wang XJ; Mokhonov VV; Shi PY; Randall R; Khromykh AA
J Virol; 2005 Feb; 79(3):1934-42. PubMed ID: 15650219
[TBL] [Abstract][Full Text] [Related]
5. Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival.
Samuel MA; Diamond MS
J Virol; 2005 Nov; 79(21):13350-61. PubMed ID: 16227257
[TBL] [Abstract][Full Text] [Related]
6. West Nile virus replication interferes with both poly(I:C)-induced interferon gene transcription and response to interferon treatment.
Scholle F; Mason PW
Virology; 2005 Nov; 342(1):77-87. PubMed ID: 16111732
[TBL] [Abstract][Full Text] [Related]
7. Attenuated West Nile viruses bearing 3'SL and envelope gene substitution mutations.
Yu L; Robert Putnak J; Pletnev AG; Markoff L
Vaccine; 2008 Nov; 26(47):5981-8. PubMed ID: 18805457
[TBL] [Abstract][Full Text] [Related]
8. West Nile virus NS2A protein facilitates virus-induced apoptosis independently of interferon response.
Melian EB; Edmonds JH; Nagasaki TK; Hinzman E; Floden N; Khromykh AA
J Gen Virol; 2013 Feb; 94(Pt 2):308-313. PubMed ID: 23114626
[TBL] [Abstract][Full Text] [Related]
9. Multiple amino acid changes at the first glycosylation motif in NS1 protein of West Nile virus are necessary for complete attenuation for mouse neuroinvasiveness.
Whiteman MC; Wicker JA; Kinney RM; Huang CY; Solomon T; Barrett AD
Vaccine; 2011 Dec; 29(52):9702-10. PubMed ID: 21945257
[TBL] [Abstract][Full Text] [Related]
10. Mutations in West Nile virus nonstructural proteins that facilitate replicon persistence in vitro attenuate virus replication in vitro and in vivo.
Rossi SL; Fayzulin R; Dewsbury N; Bourne N; Mason PW
Virology; 2007 Jul; 364(1):184-95. PubMed ID: 17382364
[TBL] [Abstract][Full Text] [Related]
11. Biological properties of chimeric West Nile viruses.
Borisevich V; Seregin A; Nistler R; Mutabazi D; Yamshchikov V
Virology; 2006 Jun; 349(2):371-81. PubMed ID: 16545851
[TBL] [Abstract][Full Text] [Related]
12. A West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse.
El Garch H; Minke JM; Rehder J; Richard S; Edlund Toulemonde C; Dinic S; Andreoni C; Audonnet JC; Nordgren R; Juillard V
Vet Immunol Immunopathol; 2008 Jun; 123(3-4):230-9. PubMed ID: 18372050
[TBL] [Abstract][Full Text] [Related]
13. Neutralization escape variant of West Nile virus associated with altered peripheral pathogenicity and differential cytokine profile.
Sapkal GN; Harini S; Ayachit VM; Fulmali PV; Mahamuni SA; Bondre VP; Gore MM
Virus Res; 2011 Jun; 158(1-2):130-9. PubMed ID: 21470570
[TBL] [Abstract][Full Text] [Related]
14. Cell-specific IRF-3 responses protect against West Nile virus infection by interferon-dependent and -independent mechanisms.
Daffis S; Samuel MA; Keller BC; Gale M; Diamond MS
PLoS Pathog; 2007 Jul; 3(7):e106. PubMed ID: 17676997
[TBL] [Abstract][Full Text] [Related]
15. A West Nile virus recombinant protein vaccine that coactivates innate and adaptive immunity.
McDonald WF; Huleatt JW; Foellmer HG; Hewitt D; Tang J; Desai P; Price A; Jacobs A; Takahashi VN; Huang Y; Nakaar V; Alexopoulou L; Fikrig E; Powell TJ
J Infect Dis; 2007 Jun; 195(11):1607-17. PubMed ID: 17471430
[TBL] [Abstract][Full Text] [Related]
16. DC-SIGN enhances infection of cells with glycosylated West Nile virus in vitro and virus replication in human dendritic cells induces production of IFN-alpha and TNF-alpha.
Martina BE; Koraka P; van den Doel P; Rimmelzwaan GF; Haagmans BL; Osterhaus AD
Virus Res; 2008 Jul; 135(1):64-71. PubMed ID: 18405996
[TBL] [Abstract][Full Text] [Related]
17. Mutations in the NS1 protein of swine influenza virus impair anti-interferon activity and confer attenuation in pigs.
Solórzano A; Webby RJ; Lager KM; Janke BH; García-Sastre A; Richt JA
J Virol; 2005 Jun; 79(12):7535-43. PubMed ID: 15919908
[TBL] [Abstract][Full Text] [Related]
18. The N- and C-terminal domains of the NS1 protein of influenza B virus can independently inhibit IRF-3 and beta interferon promoter activation.
Donelan NR; Dauber B; Wang X; Basler CF; Wolff T; García-Sastre A
J Virol; 2004 Nov; 78(21):11574-82. PubMed ID: 15479798
[TBL] [Abstract][Full Text] [Related]
19. Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis.
Desprès P; Combredet C; Frenkiel MP; Lorin C; Brahic M; Tangy F
J Infect Dis; 2005 Jan; 191(2):207-14. PubMed ID: 15609230
[TBL] [Abstract][Full Text] [Related]
20. Molecular and functional analyses of Kunjin virus infectious cDNA clones demonstrate the essential roles for NS2A in virus assembly and for a nonconservative residue in NS3 in RNA replication.
Liu WJ; Chen HB; Khromykh AA
J Virol; 2003 Jul; 77(14):7804-13. PubMed ID: 12829820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
